A Novel, Helper-Dependent, Adenovirus–Retrovirus Hybrid Vector: Stable Transduction by a Two-Stage Mechanism
Open Access
- 1 May 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (5) , 599-608
- https://doi.org/10.1006/mthe.2002.0586
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Prolonged Expression and Effective Readministration of Erythropoietin Delivered with a Fully Deleted Adenoviral VectorHuman Gene Therapy, 2000
- Recent advances in liver-directed gene therapy: implications for the treatment of dyslipidemiaCurrent Opinion in Lipidology, 2000
- Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboonsProceedings of the National Academy of Sciences, 1999
- An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgeneProceedings of the National Academy of Sciences, 1998
- A triploblast origin for Myxozoa?Nature, 1998
- Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vectorNature Biotechnology, 1997
- Adenoviral/retroviral vector chimeras: a novel strategy to achieve high‐efficiency stable transduction in vivoThe FASEB Journal, 1997
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Proceedings of the National Academy of Sciences, 1996
- Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.Proceedings of the National Academy of Sciences, 1995